Research Looks Into Radiologists’ DCIS Predictions

Thursday, March 30, 2017

Aunt Minnie (3/30, Yee) reports that research suggests “radiologists can predict the presence of invasive cancer with fairly high accuracy, but their accuracy dips when it comes to predicting ductal carcinoma in situ (DCIS).” The findings were published in American Journal of Roentgenology. 

More Women Opting for Contralateral Prophylactic Mastectomies, Research Indicates

Thursday, March 30, 2017

The New York Times (3/29, Rabin, Subscription Publication) “Well” blog reports that research published in JAMA Surgery indicates “one in three breast cancer patients under 45 removed the healthy breast along with the breast affected by cancer in 2012.” This is “a sharp increase from the one in 10 younger women with breast cancer who had double mastectomies eight years earlier.” While “the rate of double mastectomies was highest among women under 45,” the data indicated that the rate also increased among older women.

Smokers Who Receive Radiotherapy for Breast Cancer May Face Higher Risk of Lung Cancer or Heart Attack Than Non-Smokers, Study Suggests

Monday, March 27, 2017

DOT Med News (3/24, Dubinsky) reported that “smokers who receive radiotherapy for breast cancer put themselves at a higher risk of lung cancer or heart attack than non-smokers.” The findings were published in the Journal of Clinical Oncology. 

Second Opinion Review of Breast Images From Other Institutions Leads to Change in Interpretation in Nearly 30% of Patients, Research Indicates

Thursday, March 23, 2017

Aunt Minnie (3/23, Yee) reports research suggests “a second opinion review of breast images from other institutions leads to a change in interpretation – and potentially disease management decisions – in almost 30% of patients.” The findings were published online in the American Journal of Roentgenology. 

Ultrasound Findings at Mid-Neoadjuvant Treatment of Breast Cancer May Be Associated with RCB Among Patients with TNBC and HR-Negative, HER2-Positive Disease

Wednesday, March 22, 2017

Cancer Therapy Advisor (3/21, Primeau) reports that research indicated “ultrasound findings at mid-neoadjuvant (NAC) treatment of breast cancer were associated with residual cancer burden (RCB) among patients with triple-negative breast cancer (TNBC) and hormone receptor (HR)-negative, HER2-positive disease.” The findings were published in The Oncologist.